MiMedx Group Stock (NASDAQ: MDXG) stock price, news, charts, stock research, profile.
Open | $7.82 |
Close | $7.76 |
Volume / Avg. | 628.76K / 737.71K |
Day Range | 7.63 - 7.85 |
52 Wk Range | 5.57 - 9.27 |
Market Cap | $1.19B |
P/E Ratio | 14.83 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 70 |
Short Interest | 4.27% |
Days to Cover | 10.86 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of MiMedx Group (NASDAQ:MDXG) through any online brokerage.
Other companies in MiMedx Group’s space includes: Immunome (NASDAQ:IMNM), ARS Pharmaceuticals (NASDAQ:SPRY), Humacyte (NASDAQ:HUMA), Gyre Therapeutics (NASDAQ:GYRE) and Cogent Biosciences (NASDAQ:COGT).
There is no analysis for MiMedx Group.
MiMedx Group has a consensus price target of $12.00.
The stock price for MiMedx Group (NASDAQ: MDXG) is $8.0582 last updated July 26, 2024 at 6:49 PM EDT.
There are no upcoming dividends for MiMedx Group.
MiMedx Group’s Q2 earnings are confirmed for Wednesday, July 31, 2024.
There is no upcoming split for MiMedx Group.
MiMedx Group is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.